141
Participants
Start Date
August 31, 2013
Primary Completion Date
May 13, 2016
Study Completion Date
June 17, 2019
regorafenib
Patients will receive 160 mg regorafenib 1/day 3 weeks out of 4.
Jules Bordet Institute, Brussels
Hopital Erasme, Brussels
Clinique Saint Pierre, Ottignies
AZ Turnhout, Turnhout
UZA, Antwerp
Centre Hospitalier Universitaire de Liège, Liège
Clinique St Joseph, Liège
Centre Hospitalier Régional de Namur, Namur
Clinique et Maternité Sainte Elisabeth, Namur
Cliniques Universitaires UCL de Mont-Godinne, Yvoir
Grand Hopital de Charleroi, Charleroi
Centre hospitalier de Jolimont, Lobbes
CHU Ambroise Paré, Mons
AZ groeninge, Kortrijk
Hartziekenhuis Roeselare-Menen (HHRM), Roeselare
Cliniques Universitaires Saint Luc, Brussels
UZ Ghent, Ghent
Lead Sponsor
Jules Bordet Institute
OTHER